Abraham Ceesay
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 8SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 3,375453,392 held (−1%) | $32.03 | $108K | -4.3% |
| Oct 8SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 1,147452,245 held (−0%) | $30.66 | $35K | -0.0% |
| Sep 24SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 1,952457,025 held (−0%) | $39.05 | $76K | -21.5% |
| Sep 24SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 215456,810 held (−0%) | $39.86 | $9K | -23.1% |
| Sep 24SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 43456,767 held (−0%) | $41.05 | $2K | -25.3% |
| Sep 9SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 7,141460,046 held (−2%) | $45.56 | $325K | -32.7% |
| Sep 9SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 1,069458,977 held (−0%) | $46.01 | $49K | -33.4% |
| Aug 26SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 18,921467,187 held (−4%) | $49.57 | $938K | -38.2% |
| Aug 12SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 14,171523,436 held (−3%) | $45.97 | $651K | -33.3% |
| Aug 12SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 8,370515,066 held (−2%) | $46.75 | $391K | -34.4% |
| Aug 12SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 3,664511,402 held (−1%) | $46.90 | $172K | -34.6% |
| Aug 12SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 19,500491,902 held (−4%) | $48.04 | $937K | -36.2% |
| Aug 12SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 5,794486,108 held (−1%) | $48.62 | $282K | -37.0% |
| Jul 29SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 2,203537,614 held (−0%) | $42.11 | $93K | -27.2% |
| Jul 29SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 7537,607 held (−0%) | $42.74 | $299 | -28.3% |
| Jul 15SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 5,481542,546 held (−1%) | $39.72 | $218K | -22.8% |
| Jul 15SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 2,729539,817 held (−1%) | $40.57 | $111K | -24.5% |
| Jul 1SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 7,344548,903 held (−1%) | $39.77 | $292K | -22.9% |
| Jul 1SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 876548,027 held (−0%) | $40.34 | $35K | -24.0% |
| Feb 19SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 3,552558,528 held (−1%) | $29.05 | $103K | +5.5% |
| Feb 19SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 2,281556,247 held (−0%) | $29.80 | $68K | +2.9% |
| Feb 19SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 2,98322,829 held (−12%) | $29.04 | $87K | +5.5% |
| Feb 19SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 2,10020,729 held (−9%) | $29.80 | $63K | +2.9% |
| Jan 22SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 5,833562,080 held (−1%) | $26.12 | $152K | +17.3% |
| Jan 22SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 5,08325,812 held (−16%) | $26.11 | $133K | +17.4% |
| Dec 18SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 2,441571,305 held (−0%) | $28.84 | $70K | +6.3% |
| Dec 18SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 2,792568,513 held (−0%) | $30.04 | $84K | +2.0% |
| Dec 18SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 600567,913 held (−0%) | $31.04 | $19K | -1.3% |
| Dec 18SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 2,14733,831 held (−6%) | $28.84 | $62K | +6.3% |
| Dec 18SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 2,42131,410 held (−7%) | $30.04 | $73K | +2.0% |
| Dec 18SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 51530,895 held (−2%) | $31.04 | $16K | -1.3% |
| Nov 18SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 2,777576,802 held (−0%) | $24.92 | $69K | +23.0% |
| Nov 18SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 3,056573,746 held (−1%) | $25.43 | $78K | +20.5% |
| Nov 18SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 2,24238,819 held (−5%) | $24.91 | $56K | +23.0% |
| Nov 18SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 2,84135,978 held (−7%) | $25.44 | $72K | +20.5% |
| Oct 16SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 4,647580,765 held (−1%) | $25.72 | $120K | +19.2% |
| Oct 16SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 1,186579,579 held (−0%) | $26.14 | $31K | +17.3% |
| Oct 16SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 4,32841,816 held (−9%) | $25.75 | $111K | +19.0% |
| Oct 16SEC | RAPPRapport Therapeutics, Inc. | Sell Plan | 75541,061 held (−2%) | $26.17 | $20K | +17.1% |
- Sell
CEO Abraham Ceesay sold $108K of RAPP at $32.03 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Abraham Ceesay sold $35K of RAPP at $30.66 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Abraham Ceesay sold $76K of RAPP at $39.05 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Abraham Ceesay sold $9K of RAPP at $39.86 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Abraham Ceesay sold $2K of RAPP at $41.05 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Abraham Ceesay sold $325K of RAPP at $45.56 — pre-scheduled 10b5-1 plan sale.